Response to Commentary: Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19

Arvind Babu Rajendra Santosh; Keerthi Muddana; Shobha Rani Bakki

doi:10.1007/s42399-021-01033-9

Response to Commentary: Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19

SN Compr Clin Med. 2021;3(11):2205-2206. doi: 10.1007/s42399-021-01033-9. Epub 2021 Sep 14.

Authors

Arvind Babu Rajendra Santosh¹, Keerthi Muddana², Shobha Rani Bakki³

Affiliations

¹ School of Dentistry, Faculty of Medical Sciences, The University of the West Indies, Mona, Kingston, Jamaica.
² Department of Oral and Maxillofacial Pathology, Tirumala Institute of Dental Sciences and Research Centre, Nizamabad, Telangana India.
³ Department of Oral Pathology, Meghna Institute of Dental Sciences, Nizamabad, Telangana India.

Abstract

This letter is a response to commentary by Ambadasu et al. on a review article by Santosh et al. on "Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19." In their commentary, Ambadasu et al. mentioned that in the list of COVID-19 associated fungal infections, mucormycosis should be added. In this response, we provide our thoughts on including mucormycosis in COVID-19 associated fungal infections of the oral cavity. We conclude that mucormycosis surge was more prevalent during the second wave of COVID-19 infection. Majority of published reports on oral fungal infections during the years 2019 and 2020 was focused on Oral Candidiasis, whereas mucormycosis appears to be re-emerging opportunistic entry of fungal infection among COVID-19 infection due to associated risk factors. Thus, Physicians and Dentists must be cautioned that other listed opportunistic fungal infections of oral cavity may also be seen among severe COVID-19 patients.be seen among severe COVID-19 patients.

Keywords: COVID-19; Candidiasis; Corona virus; Murcormycosis; Oral cavity.

Publication types

Editorial